BCL2 and cancer: Overexpression of one of the anti-apoptotic BCL2 family proteins, MCL1, has been identified as a mechanism utilized by cancers to evade a number of standard chemotherapies, including taxanes, vinca alkaloids, platinum containing compounds, and radiation5,7–11.